The Supreme Court sided with Roche Molecular Systems over Stanford University in a patent dispute for an HIV testing kit that uses polymerase chain reaction (PCR) technology. Dr Mark Holodniy, a fellow at Stanford University and inventor of the PCR technology, was assigned by the university to conduct research at Cetus.
The Supreme Court sided with Roche Molecular Systems over Stanford University in a patent dispute for an HIV testing kit that uses polymerase chain reaction (PCR) technology. Dr Mark Holodniy, a fellow at Stanford University and inventor of the PCR technology, was assigned by the university to conduct research at Cetus. While there, he signed a contract assigning any inventions arising from his time there to Cetus; he signed a similar agreement with Stanford. Roche acquired Cetus’s rights to the test and developed and commercialized a widely used kit; Stanford sued for patent infringement.
Stanford argued that Dr Holodniy could not assign rights to Cetus due to the Bayh-Dole Act, which deals with intellectual property arising from federally funded research.
Vote in the poll and share your comments with colleagues below.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Study finds pregnancy risks higher with ART in kidney transplant recipients
July 11th 2025Women with kidney transplants who conceive through assisted reproductive technology face increased risks of complications such as hypertension, preterm birth, and cesarean delivery, according to new research.
Read More